SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe